European Medicines Agency recommends suspension of Avandia, Avandamet and Avaglim
2023.11.28
European Medicines Agency recommends suspension of Avandia, Avandamet and Avaglim
BfArM - Federal Institute for Drugs and Medical Devices
Navigation and service
